Debreceni Egyetem. Általános Orvostudományi Kar. Biofizikai és Sejtbiológiai Intézet / University of Debrecen. Faculty of Medicine. Department of Biophysics and Cell Biology
Ujlaky-Nagy, L.,
Szöllősi, J.,
Vereb, G.:
EGFR-HER2 Transactivation Viewed in Space and Time Through the Versatile Spectacles of Imaging Cytometry - Implications for Targeted Therapy.
Cytom. Part A. [Epub ahead of print], 2025.
Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1
Health Informatics
D1
Immunology and Microbiology (miscellaneous)
D1
Medical Laboratory Technology
Q1
Neuroscience (miscellaneous)
D1
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
2023
4.
Kormos, J.,
Veres, A. J.,
Imre, L.,
Mátyus, L.,
Benkő, S.,
Szöllősi, J.,
Jenei, A.:
HLA DQ protein changes the cell surface distribution pattern of HLA proteins as monitored by Förster resonance energy transfer and high-resolution electron microscopy.
Cytom. Part A. 103 (12), 978-991, 2023.
Mezősi-Csaplár, M.,
Szöllősi, J.,
Gottschalk, S.,
Vereb, G.,
Szöőr, Á.:
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models.
Cancers (Basel). 13 (17), 1-19, 2021.
Costea, T.,
Vlad, O. C.,
Miclea, L. C.,
Ganea, C.,
Szöllősi, J.,
Mocanu, M. M.:
Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer.
Int. J. Mol. Sci. 21 (2), 1-52, 2020.
Tóth, G.,
Szöllősi, J.,
Abken, H.,
Vereb, G.,
Szöőr, Á.:
A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts.
Int. J. Mol. Sci. 21 (3), 1-11, 2020.
Hajdu, T.,
Váradi, T.,
Rebenku, I.,
Kovács, T.,
Szöllősi, J.,
Nagy, P.:
Comprehensive Model for Epidermal Growth Factor Receptor Ligand Binding Involving Conformational States of the Extracellular and the Kinase Domains.
Front. Cell. Dev. Biol. 8, 1-53, 2020.
Vámosi, G.,
Friedländer, E.,
Ibrahim, S. M.,
Brock, R.,
Szöllősi, J.,
Vereb, G.:
EGF Receptor Stalls upon Activation as Evidenced by Complementary Fluorescence Correlation Spectroscopy and Fluorescence Recovery after Photobleaching Measurements.
Int. J. Mol. Sci. 20 (13), 1-22, 2019.
Váradi, T.,
Schneider, M.,
Sevcsik, É.,
Kiesenhofer, D.,
Baumgart, F.,
Batta, G.,
Kovács, T.,
Platzer, R.,
Huppa, J. B.,
Szöllősi, J.,
Schütz, G.,
Brameshuber, M.,
Nagy, P.:
Homo- and Heteroassociations Drive Activation of ErbB3.
Biophys. J. 117 (10), 1935-1947, 2019.
Costea, T.,
Nagy, P.,
Ganea, C.,
Szöllősi, J.,
Mocanu, M. M.:
Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer.
Int. J. Mol. Sci. 20 (5), 1-39, 2019.
Batta, G.,
Soltész, L.,
Kovács, T.,
Bozó, T.,
Mészár, Z. M.,
Kellermayer, M.,
Szöllősi, J.,
Nagy, P.:
Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher disease.
Sci Rep. 8 (1), 157, 2018.
Barok, M.,
Puhka, M.,
Vereb, G.,
Szöllősi, J.,
Isola, J.,
Joensuu, H.:
Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation.
BMC Cancer. 18 (1), 504-516, 2018.
Filippi, A.,
Picot, T.,
Aanei, C. M.,
Nagy, P.,
Szöllősi, J.,
Campos, L.,
Ganea, C.,
Mocanu, M. M.:
Epigallocatechin-3-gallate alleviates the malignant phenotype in A-431 epidermoid and SK-BR-3 breast cancer cell lines.
Int. J. Food Sci. Nutr. 69 (5), 584-597, 2018.
Ujlaky-Nagy, L.,
Nagy, P.,
Szöllősi, J.,
Vereb, G.:
Flow cytometric FRET analysis of protein interactions.
In: Flow Cytometry Protocols. Eds.: Teresa S. Hawley, Robert G. Hawley, Springer, New York, 393-419, 2018, (Methods in Molecular Biology, ISSN 1064-3745 ; 1678)
